Press review archive 2020

On this page, you can find all the press review of 2020

2020 – October 12

ITALFARMACO

Italfarmaco Receives FDA Rare Pediatric Disease Designation for Givinostat in Duchenne Muscular Dystrophy…

2020 – April 27

Business Wire

Italfarmaco Provides Update on Advanced-Stage Clinical Development Program with Givinostat in Duchenne Muscular Dystrophy

Read the article